• 1. Establishment and implications of a characterization method for magnetic nanoparticle using cell tracking velocimetry and magnetic susceptibility modified solutions
  Huading Zhang,Lee R. Moore,Maciej Zborowski,P. Stephen Williams,Shlomo Margel,Jeffrey J. Chalmers Analyst, 2005,130, 514-527
• 2. Fe3O4 nanoparticle chains with N-doped carbon coating: magnetotactic bacteria assisted synthesis and high-rate lithium storage?
  Dan Yang,Yanping Zhou,Xianhong Rui,Jixin Zhu,Ziyang Lu,Eileen Fong,Qingyu Yan RSC Adv., 2013,3, 14960-14962
• 3. Excitonic channels from bio-inspired templated supramolecular assembly of J-aggregate nanowires?
  Daniel Messmer,Stefan Salentinig,Jakob Heier Nanoscale, 2019,11, 6929-6938
• 4. Dissolution of cork biopolymers in biocompatible ionic liquids
  Helga Garcia,Rui Ferreira,Marija Petkovic,Jamie L. Ferguson,Maria C. Leit?o,H. Q. Nimal Gunaratne,Luís Paulo N. Rebelo Green Chem., 2010,12, 367-369
• 5. Fe3O4/PEG-SO3H as a heterogeneous and magnetically-recyclable nanocatalyst for the oxidation of sulfides to sulfones or sulfoxides
  Saeideh Mirfakhraei,Malak Hekmati,Fereshteh Hosseini Eshbala,Hojat Veisi New J. Chem., 2018,42, 1757-1761

Introduction to 3-Bromo-N-cyclopentylbenzamide (CAS No. 349405-34-1) and Its Emerging Applications in Chemical Biology

3-Bromo-N-cyclopentylbenzamide, identified by the chemical identifier CAS No. 349405-34-1, is a specialized organic compound that has garnered significant attention in the field of chemical biology due to its unique structural properties and potential biological activities. This compound belongs to the benzamide class, characterized by a benzene ring linked to an amide functional group, with modifications that enhance its pharmacological relevance. The presence of a bromine substituent at the para position of the benzene ring and a cyclopentyl group attached to the amide nitrogen introduces specific steric and electronic effects that make this molecule a valuable scaffold for drug discovery and molecular research.

The structure of 3-Bromo-N-cyclopentylbenzamide incorporates key features that contribute to its versatility in chemical biology applications. The bromine atom, being highly electronegative, influences the electron distribution in the aromatic ring, making it susceptible to various chemical reactions such as cross-coupling reactions, which are widely used in synthesizing complex molecules. Additionally, the cyclopentyl group provides a bulky, rigid structure that can interact favorably with biological targets, potentially enhancing binding affinity and selectivity. These structural attributes make 3-Bromo-N-cyclopentylbenzamide a promising candidate for developing novel therapeutic agents.

In recent years, there has been a surge in research focused on leveraging structural diversity to uncover new biological functions. The benzamide moiety, in particular, has been extensively studied for its role in modulating various biological pathways. For instance, derivatives of benzamides have shown promise in inhibiting enzymes involved in inflammation, pain perception, and cancer progression. The introduction of the 3-Bromo-N-cyclopentylbenzamide structure into this framework opens up new avenues for exploration. Researchers have been investigating its potential as an inhibitor of proteases and kinases, which are critical targets in oncology and immunology.

One of the most compelling aspects of 3-Bromo-N-cyclopentylbenzamide is its utility as a building block in medicinal chemistry. The bromine substituent allows for facile functionalization via palladium-catalyzed cross-coupling reactions, enabling the introduction of diverse pharmacophores at other positions on the benzene ring or elsewhere in the molecule. This flexibility is particularly valuable when designing molecules with tailored biological activities. Furthermore, computational studies have suggested that the cyclopentyl group may enhance solubility and metabolic stability, making 3-Bromo-N-cyclopentylbenzamide derivatives more suitable for clinical development.

Recent experimental studies have begun to elucidate the pharmacological profile of 3-Bromo-N-cyclopentylbenzamide and its derivatives. Initial assays have demonstrated inhibitory effects on certain enzymes associated with cancer cell proliferation and metastasis. For example, researchers have observed that analogs of this compound can interfere with the activity of cyclin-dependent kinases (CDKs), which are essential for cell cycle regulation. The bromine atom appears to play a crucial role in modulating these interactions by influencing the orientation and accessibility of key functional groups within the binding site.

The incorporation of 3-Bromo-N-cyclopentylbenzamide into drug discovery pipelines has also sparked interest in its potential applications beyond oncology. Studies are underway to explore its effects on inflammatory pathways and neurodegenerative diseases. The benzamide core is known to interact with receptors and ion channels involved in pain modulation, making this compound a candidate for developing novel analgesics. Preliminary data suggest that modifications to the cyclopentyl group can fine-tune pharmacological properties, leading to compounds with enhanced efficacy and reduced side effects.

The synthesis of 3-Bromo-N-cyclopentylbenzamide presents an interesting challenge due to its complex structure. Traditional synthetic routes involve multi-step processes that require careful optimization to ensure high yields and purity. Recent advances in synthetic methodologies have enabled more efficient preparation of this compound using transition metal catalysis and flow chemistry techniques. These innovations not only improve scalability but also allow for rapid screening of derivatives with different substituents.

In conclusion,3-Bromo-N-cyclopentylbenzamide (CAS No. 349405-34-1) represents a significant advancement in chemical biology research due to its unique structural features and potential biological activities. Its versatility as a scaffold for drug discovery continues to drive innovation across multiple therapeutic areas. As research progresses, it is anticipated that derivatives of this compound will emerge as promising candidates for treating various diseases, including cancer and inflammatory disorders. The ongoing exploration of its pharmacological properties underscores its importance as a cornerstone in modern medicinal chemistry.

• 6612-51-7(3-bromo-N-(pentan-3-yl)benzamide)
• 503464-88-8(3-Bromo-N-4-Piperidinyl-Benzamide)
• 59507-55-0(N-Cyclohexyl 3-bromobenzamide)
• 874886-88-1(Benzenemethanaminium, 4-[[(3-bromobenzoyl)amino]methyl]-N-cyclohexyl-N,N-dimethyl-, iodide (1:1))
• 223553-87-5(N-Cyclohexyl 4-bromobenzamide)
• 149556-36-5(Benzamide, 4-bromo-N-cyclohexyl-N-cyclopentyl-)
• 1020252-78-1(N-Cyclopentyl 4-bromo-3-methylbenzamide)
• 192875-99-3(4-Bromo-N-(piperidin-4-yl)benzamide)
• 35390-07-9(N-Butyl 3-Bromobenzamide)
• 223557-21-9(N-Cyclopentyl 4-bromobenzamide)